Invesco Ltd. Harrow Health, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 199,024 shares of HROW stock, worth $7.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

199,024

Previous 73,383 171.21%

Holding current value

$7.29 Million

Previous $1.53 Million 484.07%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$20.85 - $46.47 $2.62 Million - $5.84 Million	125,641 Added 171.21%	199,024 $8.95 Million
Q2 2024 Aug 13, 2024	BUY	$10.0 - $21.64 $596,990 - $1.29 Million	59,699 Added 436.27%	73,383 $1.53 Million
Q1 2024 May 14, 2024	SELL	$9.3 - $13.23 $92,460 - $131,532	-9,942 Reduced 42.08%	13,684 $181,000
Q4 2023 Feb 12, 2024	SELL	$8.1 - $16.36 $113,084 - $228,401	-13,961 Reduced 37.14%	23,626 $264,000
Q3 2023 Nov 13, 2023	BUY	$14.03 - $22.08 $321,258 - $505,587	22,898 Added 155.89%	37,587 $540,000
Q2 2023 Aug 11, 2023	SELL	$17.37 - $28.08 $3.85 Million - $6.23 Million	-221,908 Reduced 93.79%	14,689 $279,000
Q1 2023 May 12, 2023	BUY	$13.84 - $21.46 $1.6 Million - $2.49 Million	115,861 Added 95.96%	236,597 $5.01 Million
Q4 2022 Feb 13, 2023	BUY	$10.28 - $14.78 $1.24 Million - $1.78 Million	120,736 New	120,736 $1.78 Million
Q2 2021 Aug 17, 2021	SELL	$6.68 - $11.07 $90,888 - $150,618	-13,606 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $22,592 - $39,807	-3,609 Reduced 20.96%	13,606 $92,000
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $81,943 - $119,299	17,215 New	17,215 $118,000
Q3 2020 Nov 16, 2020	SELL	$4.71 - $7.36 $95,297 - $148,914	-20,233 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.61 - $6.47 $20,696 - $37,092	5,733 Added 39.54%	20,233 $106,000
Q1 2020 May 15, 2020	SELL	$3.5 - $7.31 $712,551 - $1.49 Million	-203,586 Reduced 93.35%	14,500 $55,000
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $949,605 - $1.63 Million	206,436 Added 1771.98%	218,086 $1.7 Million
Q3 2019 Nov 14, 2019	BUY	$4.89 - $8.0 $56,968 - $93,200	11,650 New	11,650 $65,000

Others Institutions Holding HROW

# of Institutions

177

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account